As of April 3, 2026, Carlyle Credit Income Fund 7.375% Series D Term Preferred Shares due 2028 (CCID) trades at a current price of $25.09, posting a marginal 0.04% decline in the most recent trading session. This exchange-listed preferred share, issued by affiliates of global alternative asset manager The Carlyle Group, is designed to deliver steady fixed income to holders through its stated 7.375% coupon, with a scheduled maturity in 2028. No recent earnings data is available for CCID at the ti
CCID Stock Analysis: Carlyle Credit Income Fund 7.375% Series D 2028 Preferreds Slight Dip at $25.09
CCID - Stock Analysis
4406 Comments
1836 Likes
1
Chinguun
Loyal User
2 hours ago
That moment when you realize you’re too late.
👍 150
Reply
2
Taijae
Loyal User
5 hours ago
Free US stock insights offering expert guidance, market trends, and carefully selected opportunities for safe and consistent investment growth. Our track record speaks for itself, with thousands of satisfied investors who have achieved their financial goals through our platform.
👍 76
Reply
3
Dearld
Influential Reader
1 day ago
Provides a balanced perspective on potential market outcomes.
👍 160
Reply
4
Landynn
Experienced Member
1 day ago
The current trading session shows indices maintaining positions above key support levels, suggesting resilience in market momentum. While minor retracements are possible, broad participation across sectors underpins a constructive market environment. Investors should monitor technical indicators for potential breakout opportunities.
👍 95
Reply
5
Aeko
Legendary User
2 days ago
Volatility remains moderate, with indices fluctuating around key moving averages. This reflects a balanced market where both buying and selling pressures coexist. Analysts point out that sustained strength above current support levels could signal further upside, while a sudden breakdown might trigger short-term corrections that could offer buying opportunities.
👍 260
Reply
Disclaimer: Not investment advice. For informational purposes only. Past performance does not guarantee future results. Trading involves substantial risk of loss.